Combination of Recombinant Human Erythropoietin with Iron Preparation (III) for Intravenous Administration in Oncohematology (Clinical Case)

The clinical observation of treatment of a 59-year-old patient who has been diagnosed with multiple myeloma has been presented. Anemia and iron deficiency are frequent undesirable complications in patients with multiple myeloma and haematological malignancies, including those induced by chemotherapy. The article describes the modern principles of managing patients with anemia of malignant growth, taking into account the latest recommendations of the European Society of Clinical Oncologists in 2018. Over the past years, our understanding of the importance of anemia in cancer patients has dramatically increased.

Keywords: anemia, multiple myeloma, erythropoietin, Emavail, treatment.

11 March, 2019

Learn more


Astenic syndrome in a post-covid-19 patient (review and own experience)

Among the symptoms and syndromes that dominate the clinical picture of postcoid syndrome (POST-COVID-19), the signs of asthenia, increased fatigue, excessive exhaustion during normal daily activities, which form asthenic syndrome, are highlighted. For the treatment of postcoid asthenic syndrome, a combination of pathogenetically justified agents has been proposed: podaravone (Xavron), a mixture of L-arginine and...

” Long-haulers “: patients with post-covid syndrome in routine clinical practice

At the beginning of the COVID 19 pandemic, SARS-CoV 2 disease was thought to be transient (like most respiratory viral infections). The World Health Organization later reported that the duration of a new coronavirus disease from the onset of the first symptoms to mild clinical recovery is ≈2 weeks, and in severe or moderate cases,...